N 1–2 (179–180) 2022. P. 20–24

PREDICTION OF THE DYSBIOSIS DEVELOPMENT RISK ACCORDING TO HUMORAL IMMUNITY INDICATORS

Odessa National Medical University, Odesa, Ukraine

DOI 10.54229/2226-2008-2022-1-2-3

Diseases associated with bacterial vaginosis lead to chronic inflammatory processes of the internal genitals, the development of adhesions of the pelvic organs, infertility, spontaneous abortion at different times, as well as the development of malignant neoplasms. Vaginal microflora is an indicator of a woman’s health, which can form changing in hormonal and immunological status during various pathological conditions.

The aim of the study was to create a system for prediction of the dysbiosis development according to the levels of nonspecific humoral factor of immune defense.

Materials and methods. The study was performed in 298 women aged 16 to 64 years, 53 of whom were diagnosed with normocenosis, and 245 have dysbiosis. Women were divided into 3 groups according to age. Regression analysis was used.

Research results and their discussion.

Our previous research have shown a correlation between increased levels of anti-inflammatory cytokines in the blood and vaginal secretions with the stage of dysbiosis. A logistic regression model was constructed during the study, which showed that the risk of developing dysbiosis in terms of normobiota increases with increasing levels of interleukin 2 in the blood, tumor necrosis factor α. Significant features of the three-factor model for predicting the risk of developing dysbiosis (IL2, IL4 and TNFα) were selected by the method of genetic algorithm. The levels of these indicators in the blood were related to the severity of dysbiosis according to the results of discriminant analysis.

Conclusions. Thus, a linear neural network model was developed for determination of dysbiosis severity according to the levels of nonspecific humoral factors of immune defense such as the C4 component of the complement system and γ-interferon in vaginal secretions, as well as the amount of circulating immune complexes and tumor necrosis factor α in the blood. Kappa Cohen’s agreement for this model on the training set was 0.87 (95% CI 0.82-0.91), and on the confirmatory set was 0.89 (95% CI 0.77-1.00). These indicators show the adequacy of the constructed model. The interface of the expert system for the dysbiosis severity prediction has been created.

Key words: normobiota, bacterial vaginosis, linear neural network model for determination of the dysbiosis severity, humoral factor of immune defense.

REFERENCES

1. Lusta MV. Femoflore screen as a method of diagnosis of dysbiosis in the urogenital tract of women of reproductive age. Hist: All-Ukrainian medical journal of young scientists. 2018; 20: 212 (in Ukrainian).
2. Van Nan. Prevention of a recurrent bacterial vaginosis on the basis of restoration of colonization resistance of lactobacilli by natural physical factors. Candidate’s thesis. 2017 (in Russian).
3. Tertyshnyk AO. The stage of vaginal microbiocenosis in patients with nonspecific chronic salpidogophore. Neonatology, surgery and perinatal medicine. (2016): VI 1 (19) (in Ukrainian).
4. Malanchuk LM, Malanchuk SL, & Nebeso TA., Vaginal microbiota: How to restore balance with dysbiosis]. Health of a Woman. 2016; (2): 107-111 (in Ukrainian).
5. Prilutskaya AB, Kushch VN, & Lyanenko LA. Current trends in the treatment of bacteriological disease. Health of Woman. (2016); 5 (111): 65-66 (in Russian).
6. Nechyporenko NM. Microbiological biofilms in the pathogenesis of resistance and chronic infection of the urogenital tract. Cosmetology. Sexual Pathology. 2016; 1-2 (3). (in Ukrainian).
7. Tsmur OV, Levchuk OB, Liashyna KV, & Boiko NV. Results of application of domestic synbiotics Bifitin for the treatment of bacterial vaginosis in pregnant women. Women’s Health. 2016; (6): 66-72 (in Ukrainian).
8. Nitsovych IR, Semeniak AV. Features of the course and treatment of bacterial vaginosis in pregnant women. Bukovinian State Medical University. 2016; (3): 61-64 (in Ukrainian).
9. Ananyeva MM. Etiological and pathogenetic aspects of nonspecific bacterial vaginosis. Zaporozhye Medical Journal. 2018; 20 (3). (in Russian).
10. Hruzevskyi OA. The state of the cytokine system in bacterial dysbiosis and bacterial vaginosis. Science Rise: Medical Science. 2020; (3): 50–56 (in Ukrainian).